tuberculosis
Top Five Articles on 360Dx Last Week: Lab Priorities During Elections; Cepheid TB Test Pricing; More
Last week, readers were most interested in a story about how priorities for the lab industry could play out depending on election results.
Doctors Without Borders Urges Danaher, Cepheid to Further Reduce Price of TB Tests
In an open letter, the organization called on Danaher and its subsidiary Cepheid to further lower the price of its Xpert MTB/RIF Ultra tuberculosis test.
At the ADLM annual meeting, firms said they see game-changing opportunities for platforms that provide the right combination of clinical utility and convenience.
FDA, Gates Foundation Partner to Help Develop Breath-Based Dx for Underserved Populations
The organizations will create new analytical methods for the development of breath-based diagnostic tests that can detect diseases in underserved populations.
The company plans to release Ampore-TB for research use only later this year, followed by regulatory submissions in the US and Europe.
Apr 8, 2024
Apr 27, 2023
Apr 18, 2023